Genevieve Hansen
Presidente en Vet Therapeutics, Inc. .
Cargos activos de Genevieve Hansen
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Vet Therapeutics, Inc.
Vet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Elanco Animal Health, Inc., Vet Therapeutics, Inc. develops antibodies and pharmaceutical products for animals. The company is based in Del Mar, CA. Vet Therapeutics was acquired by Aratana Therapeutics, Inc., part of Elanco Animal Health, Inc. from July 19, 2019 on October 16, 2013 for $55.29 million. | Presidente | - | - |
Vetica Labs, Inc.
Vetica Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Vetica Labs, Inc. engages in other industry group. The company is headquartered in San Diego, CA. | Director/Miembro de la Junta | - | - |
Historial de carrera de Genevieve Hansen
Antiguos cargos conocidos de Genevieve Hansen.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Diversa Corp.
Diversa Corp. Miscellaneous Commercial ServicesCommercial Services Diversa searches high and low for DNA. In its quest to develop new enzymes and other active biological compounds, the biotechnology company collects and catalogs the DNA of organisms in diverse environments (from manure piles to tropical islands). A variety of manufacturers license these compounds from the firm to develop or improve their products, which include detergents, oils, animal feeds, and pharmaceuticals. Diversa's products include enzymes for the oil and gas industry | Corporate Officer/Principal | - | - |
Lpath, Inc.
Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Director Técnico/Científico/I+D | 01/03/2006 | - |
Formación de Genevieve Hansen.
Université Paris 1 Panthéon-Sorbonne | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 5 |
Francia | 2 |
Operativa
Chief Tech/Sci/R&D Officer | 1 |
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Sectorial
Health Technology | 3 |
Commercial Services | 3 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 4 |
---|---|
Lpath, Inc.
Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Health Technology |
Diversa Corp.
Diversa Corp. Miscellaneous Commercial ServicesCommercial Services Diversa searches high and low for DNA. In its quest to develop new enzymes and other active biological compounds, the biotechnology company collects and catalogs the DNA of organisms in diverse environments (from manure piles to tropical islands). A variety of manufacturers license these compounds from the firm to develop or improve their products, which include detergents, oils, animal feeds, and pharmaceuticals. Diversa's products include enzymes for the oil and gas industry | Commercial Services |
Vet Therapeutics, Inc.
Vet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Elanco Animal Health, Inc., Vet Therapeutics, Inc. develops antibodies and pharmaceutical products for animals. The company is based in Del Mar, CA. Vet Therapeutics was acquired by Aratana Therapeutics, Inc., part of Elanco Animal Health, Inc. from July 19, 2019 on October 16, 2013 for $55.29 million. | Health Technology |
Vetica Labs, Inc.
Vetica Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Vetica Labs, Inc. engages in other industry group. The company is headquartered in San Diego, CA. | Commercial Services |
- Bolsa de valores
- Insiders
- Genevieve Hansen
- Experiencia